Taken together with other reports, our findings suggest that STAT5 signalling may be a general feature of JAK2-translocation leukemia/lymphoma and link clinical aspects of cutaneous lymphoma with physiological T-cell differentiation. Here, JAK2 is linked to lymphoma.